Abstract
Introduction. Macrophage polarization is a key mechanism of immune regulation that determines their functional plasticity. Depending on the microenvironment, macrophages differentiate into proinflammatory (M1, activated by IFN-γ and LPS) or anti-inflammatory (M2, stimulated by IL-4 and IL-13) phenotypes.
The article analyzes the molecular mechanisms of polarization, including signaling pathways (JAK-STAT, NF-κB, PPAR-γ) and metabolic shifts (glycolysis, oxidative phosphorylation). These processes open up prospects for managing inflammation and regeneration, which is important for the development of biomaterials with anti-inflammatory properties.
Objective. The purpose of this review is to systematize current data on the mechanisms of macrophage polarization to develop strategies for controlling their activity in the context of creating functional biomaterials.
Material and methods. The search for scientific sources in the PubMed, GoogleScholar, and eLibrary databases was carried out for the period 2008 – 2024. A total of 1,469 scientific sources were found. Based on the analysis of novelty, depth of study of the topic, and citation, 68 articles were selected (after excluding duplicate publications) that most fully reflect modern concepts of: classical and alternative activation of macrophages, the role of metabolic rearrangements, and epigenetic regulation.
Conclusion. Modern research reveals the complex molecular mechanisms underlying macrophage polarization. This process involves fine-tuning of signaling pathways, epigenetic modifications, and metabolic reprogramming that determine their phenotypic plasticity, which plays a key role in maintaining the balance between inflammation and regeneration. Managing macrophage polarization opens up new prospects for controlling the immune response and tissue regeneration, which is especially relevant for the development of biomaterials and implants. Their unique ability to transform makes macrophages central regulators of both physiological homeostasis and pathological processes.
Authors and affiliations
https://elibrary.ru/fvxqam T.M. Terekhova(1), P.M. Larionov(1), V.I. Larkin(2), A.E. Simonovich(1), A.S. Shershever(3), V.V. Stupak(1)
1Novosibirsk Research Institute of Traumatology and Orthopedics n.a. Ya.L. Tsivyan, Frunze Street, 17, Novosibirsk, 630091,
Russian Federation; 2Federal State Budgetary Educational Institution of Healthcare of the Russian “Omsk State
Medical University” of the Ministry of Health of the Russian Federation, Lenin Street, 12, Omsk, 644099, Russian Federation;
3Federal State Budget Educational Institution of Higher Education “Ural State Medical University” of the Ministry
of Health of the Russian Federation, Repina st., 3, Yekaterinburg, 620028, Russian Federation
References
1. Yan L., Wang J., Cai X., Liou Y.-C., Shen H.-M., Hao J., Huang C., Luo G., He W. Macrophage plasticity: signaling pathways, tissue repair, and regeneration. MedComm. 2020; 5 (8): e658. DOI: https://doi.org/10.1002/mco2.658.
2. Лыков А.П., Белогородцев С.Н., Немкова Е.К., Ветлугина А., Терехова Т.М., Шварц Я.Ш. Влияние мевалоната, золедроната и БЦЖ-индукции на фенотип моноцитов/макрофагов. Сибирский научный медицинский журнал. 2023; 43 (3): 57–63. DOI: https://doi.org/10.18699/SSMJ20230306. [Lykov A.P., Belogorodtsev S.N., Nemkova E.K., Vetlugina A., Terekhova T.M., Schwartz Ya.Sh. Effect of mevalonate, zoledronate and BCG on monocyte/macrophage phenotype. Siberian Scientific Medical J. 2023; 43 (3): 57–63. DOI: https://doi.org/10.18699/SSMJ20230306 (in Russian)].
3. Lawrence T., Natoli G. Transcriptional regulation of macrophage polarization: enabling diversity with identity. Nat. Rev. Immunol. 2011; 11 (11): 750–61. DOI: https://doi.org/10.1038/nri3088.
4. Sica A., Mantovani A. Macrophage plasticity and polarization: in vivo veritas. J. Clin. Invest. 2012; 122 (3): 787–95. DOI: https://doi.org/10.1172/JCI59643.
5. van Furth R., Cohn Z.A. The origin and kinetics of mononuclear phagocytes. J. Exp. Med. 1968; 128 (3): 415–35. DOI: https://doi.org/10.1084/jem.128.3.415.
6. Murphy K., Weaver C. Janeway’s Immunobiology. 9th ed. New York: Garland Science, 2017; 904.
7. Ginhoux F., Guilliams M. Tissue-resident macrophage ontogeny and homeostasis. Immunity. 2016; 44 (3): 439–49. DOI: https://doi.org/10.1016/j.immuni.2016.02.018.
8. Ginhoux F., Jung S. Monocytes and macrophages: developmental pathways and tissue homeostasis. Nat. Rev. Immunol. 2014; 14 (6): 392–404. DOI: https://doi.org/10.1038/nri3671.
9. Viola M.F., Franco Taveras E., Mass E. Developmental programming of tissue-resident macrophages. Front Immunol. 2024; 15: 1475369. DOI: 10.3389/fimmu.2024.1475369. PMID: 39575254; PMCID: PMC11578957.
10. Guilliams M., Scott C.L. Does niche competition determine the origin of tissue-resident macrophages? Nat. Rev. Immunol. 2017; 17 (7): 451–60. DOI: https://doi.org/10.1038/nri.2017.42.
11. Hashimoto D., Chow A., Noizat C., Teo P., Beasley M.B., Leboeuf M., Becker C.D., See P., Price J., Lucas D., Greter M., Mortha A., Boyer S.W., Forsberg E.C., Tanaka M., van Rooijen N., Garcia-Sastre A., Stanley E.R., Ginhoux F., Frenette P.S., Merad M.. Tissue-resident macrophages self-maintain locally throughout adult life with minimal contribution from circulating monocytes. Immunity. 2013; 38 (4): 792–804. DOI: https://doi.org/10.1016/j.immuni.2013.04.004
12. Yona S., Gordon S. From the reticuloendothelial to mononuclear phagocyte system – the unaccounted years. Front. Immunol. 2015; 6: 328. DOI: https://doi.org/10.3389/fimmu.2015.00328
13. Amit I., Winter D.R., Jung S. The role of the local environment and epigenetics in shaping macrophage identity and their effect on tissue homeostasis. Nat. Immunol. 2016; 17 (1): 18–25. DOI: https://doi.org/10.1038/ni.3325
14. Santa K. Macrophages: Phagocytosis, Antigen Presentation, and Activation of Immunity. Physiology. London: IntechOpen, 2023. URL: http://dx.doi.org/10.5772/intechopen.110832
15. Gordon S., Martinez F.O. Alternative activation of macrophages: mechanism and functions. Immunity. 2010; 32 (5): 593–604. DOI: https://doi.org/10.1016/j.immuni.2010.05.007
16. Peter J. Murray, Judith E. Allen, Subhra K. Biswas, Edward A. Fisher, Derek W. Gilroy, Sergij Goerdt, Siamon Gordon, John A. Hamilton, Lionel B. Ivashkiv, Toby Lawrence, Massimo Locati, Alberto Mantovani, Fernando O. Martinez, Jean-Louis Mege, David M. Mosser, Gioacchino Natoli, Jeroen P. Saeij, Joachim L. Schultze, Kari Ann Shirey, Antonio Sica, Jill Suttles, Irina Udalova, Jo A. van Ginderachter, Stefanie N. Vogel, and Thomas A. Wynn. Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity. 2014; 41 (1): 14–20. DOI: https://doi.org/10.1016/j.immuni.2014.06.008
17. Tang W., Wang X., Han B., et al. Tumor-associated macrophages in cancer: from mechanisms to application. Mol. Biomed. 2025; 6: 145. DOI: https://doi.org/10.1186/s43556-025-00396-y.
18. Locati M., Curtale G., Mantovani A. Diversity, mechanisms, and significance of macrophage plasticity. Annu. Rev. Pathol. 2020; 15: 123–47. DOI: https://doi.org/10.1146/annurev-pathmechdis-012418-012718.
19. Barnett K.C., Li S., Liang K., Ting J.P. A 360° view of the inflammasome: Mechanisms of activation, cell death, and diseases. Cell. 2023; 186 (11): 2288–312. DOI: https://doi.org/10.1016/j.cell.2023.04.025.
20. Gordon S., Plüddemann A. Tissue macrophages: heterogeneity and functions. BMC Biol. 2017; 15 (1): 53. DOI: https://doi.org/10.1186/s12915-017-0392-4.
21. Strizova Z., Benesova I., Bartolini R., Novysedlak R., Cecrdlova E., Foley L.K., Striz I. M1/M2 macrophages and their overlaps – myth or reality? Clin. Sci. 2023; 137 (15): 1067–93. DOI: https://doi.org/10.1042/CS20220531
22. Orihuela R., McPherson C.A., Harry G.J. Microglial M1/M2 polarization and metabolic states. Br. J. Pharmacol. 2016; 173 (4): 649–65. DOI: https://doi.org/10.1111/bph.13139
23. Paolicelli R.C., Sierra A., Stevens B. et al. Microglia states and nomenclature: A field at its crossroads. Neuron. 2022; 110 (21): 3458–83. DOI: https://doi.org/10.1016/j.neuron.2022.10.020.
24. Chaterjee O., Sur D. Artificially induced in situ macrophage polarization: An emerging cellular therapy for immuno-inflammatory diseases. Eur. J. Pharmacol. 2023; 957: 176006. DOI: https://doi.org/10.1016/j.ejphar.2023.176006.
25. Karim M.R., Hossain D., Uddin A., M., Rume F., I. Role of macrophages in tumor development. Recent Advancements in Microbial Diversity. Еd. Cho J.Y. London: Academic Press, 2022; 113–64. ISBN 978-0-12-822368-0. DOI: https://doi.org/10.1016/B978-0-12-822368-0.00007-4
26. Chen S., Saeed A., Liu Q., Jiang Q., Xu H., Xiao G.G., Rao L., Duo Y. Macrophages in immunoregulation and therapeutics. Signal Transduct. Target. Ther. 2023; 8: 207. DOI: https://doi.org/10.1038/s41392-023-01452-1
27. Zhou C. et al. TRAF6 promotes IL-4-induced M2 macrophage activation by stabilizing STAT6. Mol. Immunol. 2020; 127: 223–9. DOI: https://doi.org/10.1016/j.molimm.2020.09.001.
28. Yu T. et al. Modulation of M2 macrophage polarization by the crosstalk between Stat6 and Trim24. Nat. Commun. 2019; 10: 4353. DOI: https://doi.org/10.1038/s41467-019-12384-2.
29. Lee Y.J. et al. STAT6 Signaling Mediates PPARγ Activation and Resolution of Acute Sterile Inflammation in Mice. Cells. 2021; 10 (3): 501. DOI: https://doi.org/10.3390/cells10030501.
30. O’Neill L.A., Kishton R.J., Rathmell J. A guide to immunometabolism for immunologists. Nat. Rev. Immunol. 2016; 16 (9): 553–65. DOI: https://doi.org/10.1038/nri.2016.70.
31. Chen S. et al. Epigenetic regulation of macrophages: from homeostasis maintenance to host defense. Cell. Mol. Immunol. 2020; 17 (1): 36–49. DOI: https://doi.org/10.1038/s41423-019-0315-0.
32. Zhang Q. et al. Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6. Nature. 2015; 525 (7569): 389–93. DOI: https://doi.org/10.1038/nature15252.
33. Komal S., Han S.N., Cui L.G. et al. Epigenetic regulation of macrophage polarization in cardiovascular diseases. Pharmaceuticals. 2023; 16 (2): 141. DOI: https://doi.org/10.3390/ph16020141.
34. Zhang K., Jagannath C. Crosstalk between metabolism and epigenetics during macrophage polarization. Epigenetics & Chromatin. 2025; 18: 16. DOI: https://doi.org/10.1186/s13072-025-00575-9.
35. Schlüter T., van Elsas Y., Priem B. et al. Trained immunity: induction of an inflammatory memory in disease. Cell Res. 2025; 35: 792–802. DOI: https://doi.org/10.1038/s41422-025-01171-y.
36. Divangahi M., Aaby P., Khader S.A. et al. Trained immunity, tolerance, priming and differentiation: distinct immunological processes. Nat. Immunol. 2021; 22: 2–6. DOI: https://doi.org/10.1038/s41590-020-00845-6.
37. O’Connell R.M. et al. Inositol phosphatase SHIP1 is a primary target of miR-155. Proc. Natl. Acad. Sci. USA. 2009; 106 (17): 7113–8. DOI: https://doi.org/10.1073/pnas.0902636106.
38. Cui H. et al. Long noncoding RNA Malat1 regulates differential activation of macrophages and response to lung injury. JCI Insight. 2019; 4 (4): e124522. DOI: https://doi.org/10.1172/jci.insight.124522.
39. Galván-Peña S., O’Neill L.A. Metabolic reprogramming in macrophage polarization. Front. Immunol. 2014; 5: 420. DOI: https://doi.org/10.3389/fimmu.2014.00420.
40. Huang S.C. et al. Cell-intrinsic lysosomal lipolysis is essential for alternative activation of macrophages. Nat. Immunol. 2014; 15 (9): 846–55. DOI: https://doi.org/10.1038/ni.2956.